134 related articles for article (PubMed ID: 34819098)
1. IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma.
Wei R; Qi G; Zeng Z; Shen N; Wang Z; Shen H; Gao L; Song C; Ma W; Wang C
Cancer Cell Int; 2021 Nov; 21(1):620. PubMed ID: 34819098
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis.
Ma W; Wang B; Zhang Y; Wang Z; Niu D; Chen S; Zhang Z; Shen N; Han W; Zhang X; Wei R; Wang C
Cancer Cell Int; 2019; 19():239. PubMed ID: 31528121
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
6. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
Atay S
PeerJ; 2020; 8():e10141. PubMed ID: 33194391
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
Li A; Hou S; Chen J; Jiang Y
Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
[TBL] [Abstract][Full Text] [Related]
8. The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma.
Lu H; Zheng LY; Wu LY; Chen J; Xu N; Mi SC
Front Oncol; 2022; 12():978921. PubMed ID: 36147906
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
10. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
Front Genet; 2020; 11():610350. PubMed ID: 33584809
[No Abstract] [Full Text] [Related]
11.
Yang Y; Ren L; Li S; Zheng X; Liu J; Li W; Fu W; Wang J; Du G
Transl Cancer Res; 2022 Apr; 11(4):649-668. PubMed ID: 35571651
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
Li Y; Liu Z; Zhang Y
BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
[TBL] [Abstract][Full Text] [Related]
13. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF
J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
16. Autophagy Regulatory Genes MET and RIPK2 Play a Prognostic Role in Pancreatic Ductal Adenocarcinoma: A Bioinformatic Analysis Based on GEO and TCGA.
Li X; Li Z; Zhu H; Yu X
Biomed Res Int; 2020; 2020():8537381. PubMed ID: 33204717
[TBL] [Abstract][Full Text] [Related]
17. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma.
Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C
Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729
[TBL] [Abstract][Full Text] [Related]
18. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
19. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
[No Abstract] [Full Text] [Related]
20. Development and validation of a prognostic prediction model for iron metabolism-related genes in patients with pancreatic adenocarcinoma.
Wei W; Cao B; Xu D; Liu Y; Zhang X; Wang Y
Front Genet; 2022; 13():1058062. PubMed ID: 36685915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
